Professor of Medicine, Massachusetts General Hospital
Internal Medicine
Dr. David C. Hooper, MD
|
|
Give Review
Dr. David C. Hooper practices Internal Medicine. He researched medicine at Washington University School of Medicine in St. Louis. David Hooper is also a published doctor. He has 88 paper published. The most recent paper is: Antimicrobial blue light inactivation of gram-negative pathogens in biofilms: in vitro and in vivo studies. Doctor David C. Hooper, MD accepts Medicare.
Publications
- Impact of rapid screening for discontinuation of methicillin-resistant Staphylococcus aureus contact precautions.
- Antimicrobial blue light inactivation of gram-negative pathogens in biofilms: in vitro and in vivo studies.
- Functions of a GyrBA Fusion Protein and Its Interaction with QnrB and Quinolones.
- Housestaff Knowledge Related to Urinary Catheter Use and Catheter-Associated Urinary Tract Infections.
- The Protective Effect of Qnr on Agents Other than Quinolones that Target DNA Gyrase.
- Clinical importance and epidemiology of quinolone resistance.
- In Memoriam: Morton N. Swartz.
- The Editors' Response to Letter from Dr. Korch.
- Comparative Evaluation of the Tolerability of Cefazolin and Nafcillin for Treatment of Methicillin-Susceptible Staphylococcus aureus Infections in the Outpatient Setting.
- QnrS1 structure-activity relationships.
- Cefepime versus other antibacterial agents for the treatment of Enterobacter species bacteremia.
- Regulation of Expression of abcA and Its Response to Environmental Conditions.
- Association between fluoroquinolone resistance and resistance to other antimicrobial agents among Escherichia coli urinary isolates in the outpatient setting: a nation...
- Concordance of PCR and culture from nasal swabs for MRSA in setting of concurrent anti-staphylococcal antibiotics.
- Native Efflux Pumps Contribute Resistance to Antimicrobials of Skin and the Ability of Staphylococcus aureus to Colonize Skin.
- Mutational analysis of quinolone resistance protein QnrB1.
- Moenomycin Resistance Mutations in Staphylococcus aureus Reduce Peptidoglycan Chain Length and Cause Aberrant Cell Division.
- Novel Clostridium botulinum Toxin and Dual Use Research of Concern Issues.
- Association of norB overexpression and fluoroquinolone resistance in clinical isolates of Staphylococcus aureus from Korea.
- Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomi...
- Induction of plasmid-encoded qnrS1 in Escherichia coli by naturally occurring quinolones and quorum-sensing signal molecules.
- Discontinuation of Contact Precautions for Methicillin-Resistant Staphylococcus aureus (MRSA): A Randomized Controlled Trial Comparing Passive and Active Screening wit...
- Abrupt Emergence of a Single Dominant Multidrug-Resistant Strain of Escherichia coli.
- Phylogenetic Analysis of Chromosomally-determined Qnr and related Proteins.
- National Survey of Infection Preventionists: Policies for Discontinuation of Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resista...
- Staphylococcus aureus NorD, a putative efflux pump coregulated with the Opp1 oligopeptide permease, contributes selectively to fitness in vivo.
- Enhanced surgical site infection surveillance following hysterectomy, vascular, and colorectal surgery.
- Resource Burden Associated with Contact Precautions for Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: The Patient Access Managers'...
- Emergency department visit rates for abscess versus other skin infections during the emergence of community-associated methicillin-resistant Staphylococcus aureus, 199...
- Use of Medicare Diagnosis and Procedure Codes to Improve Detection of Surgical Site Infections following Hip Arthroplasty, Knee Arthroplasty, and Vascular Surgery.
- Quinolone Induction of qnrVS1 in Vibrio splendidus and of Plasmid-Encoded qnrS1 in Escherichia coli : Mechanisms Independent of the SOS System.
- Citrobacter spp. as a source of qnrB alleles.
- Structure of QnrB1, a plasmid-mediated fluoroquinolone resistance factor.
- Implication of the NorB Efflux Pump in the Adaptation of S. aureus to Growth at Acid pH and Resistance to Moxifloxacin.
- Impact of Ciprofloxacin Exposure on Staphylococcus aureus Genomic Alterations Linked with Emergence of Rifampin Resistance.
- Cold shock induces qnrA expression in Shewanella algae.
- Hospital-acquired infections due to gram-negative bacteria.
- Phosphorylation of MgrA and its effect on expression of the NorA and NorB efflux pumps of Staphylococcus aureus.
- Transferable quinolone resistance in Vibrio cholerae.
- Plasmid-mediated quinolone resistance: a multifaceted threat.
- Epidemiology of dermatitis and skin infections in United States physicians' offices, 1993-2005.
- oqxAB encoding a multidrug efflux pump in human clinical isolates of Enterobacteriaceae.
- New plasmid-mediated quinolone resistance gene, qnrC, found in a clinical isolate of Proteus mirabilis.
- Temporal appearance of plasmid-mediated quinolone resistance genes.
- Prevalence of plasmid-mediated quinolone resistance determinants over a 9-year period.
- SOS regulation of qnrB expression.
- NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses.
- Posttranslational modification influences the effects of MgrA on norA expression in Staphylococcus aureus.
- Mechanistic and structural analysis of aminoglycoside N-acetyltransferase AAC(6')-Ib and its bifunctional, fluoroquinolone-active AAC(6')-Ib-cr variant.
- Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicill...
- The transcriptional regulators NorG and MgrA modulate resistance to both quinolones and beta-lactams in Staphylococcus aureus.
- Antibiotic dosing before primary hip and knee replacement as a pay-for-performance measure.
- Prevalence in the United States of aac(6')-Ib-cr encoding a ciprofloxacin-modifying enzyme.
- The worldwide emergence of plasmid-mediated quinolone resistance.
- Plasmid-mediated quinolone resistance in non-Typhi serotypes of Salmonella enterica.
- An improved expression plasmid for affinity purification of Staphylococcus aureus gyrase A subunit.
- qnrB, another plasmid-mediated gene for quinolone resistance.
- NorC, a new efflux pump regulated by MgrA of Staphylococcus aureus.
- Role of the extended alpha4 domain of Staphylococcus aureus gyrase A protein in determining low sensitivity to quinolones.
- Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase.
- DX-619, a novel des-fluoro(6) quinolone manifesting low frequency of selection of resistant Staphylococcus aureus mutants: quinolone resistance beyond modification of ...
- A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus.
- Fungus-infected fluid collections in thorax or abdomen: effectiveness of percutaneous catheter drainage.
- Interaction of the plasmid-encoded quinolone resistance protein QnrA with Escherichia coli topoisomerase IV.
- Efflux pumps and nosocomial antibiotic resistance: a primer for hospital epidemiologists.
- Dual targeting of topoisomerase IV and gyrase to reduce mutant selection: direct testing of the paradigm by using WCK-1734, a new fluoroquinolone, and ciprofloxacin.
- Interaction of the plasmid-encoded quinolone resistance protein Qnr with Escherichia coli DNA gyrase.
- Enhanced identification of postoperative infections among inpatients.
- Activities of newer quinolones against Escherichia coli and Klebsiella pneumoniae containing the plasmid-mediated quinolone resistance determinant qnr.
- Emerging plasmid-mediated quinolone resistance associated with the qnr gene in Klebsiella pneumoniae clinical isolates in the United States.
- A recA-LexA-dependent pathway mediates ciprofloxacin-induced fibronectin binding in Staphylococcus aureus.
- Quinolone resistance due to reduced target enzyme expression.
- Fluoroquinolones and the risk for methicillin-resistant Staphylococcus aureus in hospitalized patients.
- Detection of postoperative surgical-site infections: comparison of health plan-based surveillance with hospital-based programs.
- Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China.
- Characterization of NorR protein, a multifunctional regulator of norA expression in Staphylococcus aureus.
- Activity of and resistance to moxifloxacin in Staphylococcus aureus.
- Topoisomerase targeting with and resistance to gemifloxacin in Staphylococcus aureus.
- Dual targeting of DNA gyrase and topoisomerase IV: target interactions of garenoxacin (BMS-284756, T-3811ME), a new desfluoroquinolone.
- Fluoroquinolone resistance among Gram-positive cocci.
- NorA functions as a multidrug efflux protein in both cytoplasmic membrane vesicles and reconstituted proteoliposomes.
- Bactericidal activities of BMS-284756, a novel Des-F(6)-quinolone, against Staphylococcus aureus strains with topoisomerase mutations.
- Mechanisms of fluoroquinolone resistance.
- Structure of grepafloxacin relative to activity and safety profile.
- Natural history of colonization with methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococcus (VRE): a systematic review.
- Plasmid-mediated quinolone resistance.
- Effect of a drug allergy educational program and antibiotic prescribing guideline on inpatient clinical providers' antibiotic prescribing knowledge.
Schools
Washington Center School of Medicine
Mass Gen Hospital
Doctors Specialties
- Infectious Disease Medicine
- Internal Medicine
Accepted Insurances
Education
-
Massachusetts General Hospital -
Washington University School of Medicine in St. Louis
Hospital
-
Massachusetts General Hospital
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1639155039 |
| Last Name Of The Provider | HOOPER |
| First Name Of The Provider | DAVID |
| View All |
Similar Doctors
|
|
Dr. Ann Y. Kao, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Emily P. Hyle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amy K. Barczak, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Oladapo A. Abodunde, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Scott L. Peterson, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Francisco M. Salgueiro, MD |
|
|
Dr. Michael Herce, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard L. Maas, MD |
|
|
Dr. Amber B. Moore, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yehuda Z. Cohen, MD |
|
|
Dr. Elizabeth Kass, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mayssam Nehme, MD |
|
|
Dr. Delvina Hasimja Saraqini, MD |
|
|
Dr. Maria Lonshteyn, MD |